
News|Articles|May 23, 2024
Eurofins MDT adds biological evaluations to support biocompatibility strategies
Author(s)Eurofins BioPharma Product Testing
The Toxicology Team in Lancaster now offers expanded services including biological evaluations to help clients with biocompatibility strategies and regulatory compliance. We provide tailored consulting for specific needs like mitigating biological risks due to product changes or failed tests. Each project is evaluated individually, ensuring customized solutions and enhanced client value.
Trending on Pharmaceutical Technology
1
CPHI Milan Names 2026 Pharma Awards Finalists
2
Lilly's $2.875B Merida Deal Has Implications for Autoantibody Diseases
3
From Phase 1 Screening to Commercial Strategy: Selecting the Right Amorphous Solid Dispersion Technology Early
4
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1
5
